Tesamorelin

20mg — Research Grade

$129.00CAD

Growth hormone releasing hormone (GHRH) analog researched for its potent lipolytic effects — particularly visceral fat reduction. Higher-dose 20mg vial for extended research protocols or studies requiring larger reconstitution volumes. FDA-approved as Egrifta for lipodystrophy. Stimulates endogenous GH production along the natural pulsatile axis.

Third-party HPLC lab tested — 99%+ purity verified

Express 1-3 day delivery — $25 flat rate · Free over $299.00

Payment via Interac e-Transfer

For research use only

SKU: TES20